Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence - PubMed (original) (raw)
. 1995 Jun 16;270(24):14255-8.
doi: 10.1074/jbc.270.24.14255.
Affiliations
- PMID: 7782278
- DOI: 10.1074/jbc.270.24.14255
Free article
Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
Y Z Lin et al. J Biol Chem. 1995.
Free article
Abstract
To control agonist-induced nuclear translocation of transcription factor kappa B (NF-kappa B) in intact cells, cell-permeable synthetic peptides were devised. Their import into intact cells was dependent on a hydrophobic region selected from the signal peptide sequences and was verified by their inaccessibility to extracellular proteases and by confocal laser scanning microscopy. When a cell-permeable peptide carried a functional cargo representing the nuclear localization sequence of NF-kappa B p50, it inhibited in a concentration-dependent manner nuclear translocation of NF-kappa B in cultured endothelial and monocytic cells stimulated with lipopolysaccharide or tumor necrosis factor-alpha. Synthetic peptide analogues with deleted hydrophobic cell membrane-permeable motif or with a mutated nuclear localization sequence were inactive. Cell membrane-permeable peptides were not cytotoxic within the concentration range used in these experiments. These results suggest that cell-permeable synthetic peptides carrying a functional cargo can be applied to control signal transduction-dependent subcellular traffic of transcription factors mediating the cellular responses to different agonists. Moreover, this approach can be used to study other intracellular processes involving proteins with functionally distinct domains.
Similar articles
- A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes.
Huang TT, Kudo N, Yoshida M, Miyamoto S. Huang TT, et al. Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1014-9. doi: 10.1073/pnas.97.3.1014. Proc Natl Acad Sci U S A. 2000. PMID: 10655476 Free PMC article. - Peptide-directed suppression of a pro-inflammatory cytokine response.
Liu XY, Robinson D, Veach RA, Liu D, Timmons S, Collins RD, Hawiger J. Liu XY, et al. J Biol Chem. 2000 Jun 2;275(22):16774-8. doi: 10.1074/jbc.C000083200. J Biol Chem. 2000. PMID: 10751381 - A D-amino acid peptide inhibitor of NF-kappa B nuclear localization is efficacious in models of inflammatory disease.
Fujihara SM, Cleaveland JS, Grosmaire LS, Berry KK, Kennedy KA, Blake JJ, Loy J, Rankin BM, Ledbetter JA, Nadler SG. Fujihara SM, et al. J Immunol. 2000 Jul 15;165(2):1004-12. doi: 10.4049/jimmunol.165.2.1004. J Immunol. 2000. PMID: 10878377 - Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization.
Agou F, Courtois G, Chiaravalli J, Baleux F, Coïc YM, Traincard F, Israël A, Véron M. Agou F, et al. J Biol Chem. 2004 Dec 24;279(52):54248-57. doi: 10.1074/jbc.M406423200. Epub 2004 Oct 5. J Biol Chem. 2004. PMID: 15466857
Cited by
- Elevated WTAP promotes hyperinflammation by increasing m6A modification in inflammatory disease models.
Ge Y, Chen R, Ling T, Liu B, Huang J, Cheng Y, Lin Y, Chen H, Xie X, Xia G, Luo G, Yuan S, Xu A. Ge Y, et al. J Clin Invest. 2024 May 16;134(14):e177932. doi: 10.1172/JCI177932. J Clin Invest. 2024. PMID: 39007267 Free PMC article. - Natural compound Alternol actives multiple endoplasmic reticulum stress-responding pathways contributing to cell death.
Liu W, He C, Li C, Ye S, Zhao J, Zhu C, Wang X, Ma Q, Li B. Liu W, et al. Front Pharmacol. 2024 May 20;15:1397116. doi: 10.3389/fphar.2024.1397116. eCollection 2024. Front Pharmacol. 2024. PMID: 38831880 Free PMC article. - Advances and transgressions of nuclear transport checkpoint inhibitors.
Hawiger J. Hawiger J. Mol Ther. 2024 May 1;32(5):1181-1184. doi: 10.1016/j.ymthe.2024.03.021. Epub 2024 Apr 4. Mol Ther. 2024. PMID: 38574737 No abstract available. - Immune Potentiation of PLGA Controlled-Release Vaccines for Improved Immunological Outcomes.
Cassaidy BJ, Moser BA, Solanki A, Chen Q, Shen J, Gotsis K, Lockhart Z, Rutledge N, Rosenberger MG, Dong Y, Davis D, Esser-Kahn AP. Cassaidy BJ, et al. ACS Omega. 2024 Feb 28;9(10):11608-11614. doi: 10.1021/acsomega.3c06552. eCollection 2024 Mar 12. ACS Omega. 2024. PMID: 38496947 Free PMC article. - Delineating the Role of GxxxG Motif in Amyloidogenesis: A New Perspective in Targeting Amyloid-Beta Mediated AD Pathogenesis.
Sarkar D, Bhunia A. Sarkar D, et al. ACS Bio Med Chem Au. 2023 Oct 31;4(1):4-19. doi: 10.1021/acsbiomedchemau.3c00055. eCollection 2024 Feb 21. ACS Bio Med Chem Au. 2023. PMID: 38404748 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials